Glibenclamide interferes with mitochondrial bioenergetics by inducing changes on membrane ion permeability
- J Biochem Mol Toxicol. 2004;18(3):162-9. doi: 10.1002/jbt.20022.
- 1. Departamento de Zoologia, Universidade de Coimbra, 3004-517 Coimbra, Portugal. [email protected]
The interference of glibenclamide, an antidiabetic sulfonylurea, with mitochondrial bioenergetics was assessed on mitochondrial ion fluxes (H+, K+, and Cl-) by passive osmotic swelling of rat liver mitochondria in K-acetate, KNO3, and KCl media, by O2 consumption, and by mitochondrial transmembrane potential (Deltapsi). Glibenclamide did not permeabilize the inner mitochondrial membrane to H+, but induced permeabilization to Cl- by opening the inner mitochondrial anion channel (IMAC). Cl- influx induced by glibenclamide facilitates K+ entry into mitochondria, thus promoting a net Cl-/K+ cotransport, Deltapsi dissipation, and stimulation of state 4 respiration rate. It was concluded that glibenclamide interferes with mitochondrial bioenergetics of rat liver by permeabilizing the inner mitochondrial membrane to Cl- and promoting a net Cl-/K+ cotransport inside mitochondria, without significant changes on membrane permeabilization to H+.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
Research Areas: Metabolic Disease
-
Research Areas: Metabolic Disease
-
target: Isotope-Labeled Compounds; Potassium Channel; Mitochondrial Metabolism; Autophagy; CFTR; P-glycoproteinResearch Areas: Metabolic Disease
-
target: CFTR; Autophagy; Reference Standards; Potassium Channel; P-glycoprotein; Mitochondrial MetabolismResearch Areas: Metabolic Disease
-
target: CFTR; Autophagy; Potassium Channel; P-glycoprotein; Isotope-Labeled Compounds; Mitochondrial MetabolismResearch Areas: Metabolic Disease